MAPT and Alzheimer disease: Within each diagnostic group, the positive association between CSF sTREM2 and T‐tau or P‐tau181P was present (Fig 3A–D), except for the association between CSF sTREM2 and T‐tau in the MCI‐AD group (β = +0.184, P = 0.098).